Skip to content
Medical Health Aged Care, Research Development

Ian Constable Research Fellow Appointed

Lions Eye Institute 2 mins read
Associate Professor Holly Chinnery

The Lions Eye Institute and The University of Western Australia are delighted to announce the appointment of Associate Professor Holly Chinnery as the inaugural Ian Constable Research Fellow.

An internationally renowned expert in the field of corneal inflammation, Associate Professor Chinnery completed her PhD at The University of Western Australia and subsequently conducted postdoctoral research at the Lions Eye Institute and Monash University.

The Lions Eye Institute’s Managing Director, Professor Bill Morgan said the appointment would bolster research capacity and further strengthen the Institute’s position at the forefront of sight saving research. “Associate Professor Chinnery will build on and expand her research activities at the Lions Eye Institute to build a corneal ocular surface platform and team. Her research will bridge the gap between basic immunology science at the Institute and enhance clinical translation.”

Associate Professor Chinnery said her work aims to understand how the corneal nervous and immunological systems interact in the context of homeostasis, inflammation, injury, and neurodegenerative diseases.

“Corneal immunology is a fascinating field that explores the intricate interactions between the immune system and the cornea - the transparent front surface of the eye,” she said.

“My research program uses preclinical models to investigate fundamental ocular immunology and explore novel therapies for corneal neuropathy and inflammation. Ultimately, the aim is to model conditions that affect the human ocular surface to improve and develop new treatments for patients whose sight has been lost to corneal disease, surface diseases, dry eyes and allied conjunctival pain syndromes.”

Associate Professor Chinnery will assume her position in April this year at the Lions Eye Institute, and will also hold an appointment dedicated to research and teaching at the UWA Optometry School.

“The ambitious goal to further augment the Lions Eye Institute’s understanding of a varied range of eye disorders through cutting edge research informed the decision to create two prestigious Ian Constable Research Fellow positions. Active recruitment is ongoing to fill the second of these posts,” said Professor Morgan.

In 2011, Associate Professor Chinnery established her own research group in Corneal Immunology at Deakin University. In 2013, she joined the Department of Optometry and Vision Sciences at The University of Melbourne, based at the Melbourne Brain Centre, co-founding the FrontTear Research Centre. This research uses in vivo and ex vivo confocal imaging techniques to visualise and monitor dynamic immunological signatures in the human eye. She also supervises seven PhD students.

Key Facts:

New research to improve and develop new treatments for people with corneal (ocular surface) disease, dry eye and more.

About us:

At the Lions Eye Institute, we make a difference to people’s lives through excellent patient care and by pushing the frontiers of science to discover new treatments and cures for eye disease. As a not-for-profit organisation, the Lions Eye Institute spans the dual complementary pathways of research and clinical care. We bring together a globally recognised team of researchers and clinicians who continually build on each other’s discoveries, knowledge and expertise to deliver sight-saving treatment and care around the world. The quest for knowledge and its life-changing applications for patients drives our work. For more Lions Eye Institute media stories, visit our news page.

Contact details:

Caroline Vincent

Communications Manager

(08) 9381 0738


More from this category

  • Government NSW, Medical Health Aged Care
  • 12/07/2024
  • 12:39
MEDIA RELEASE - Network of Alcohol & Other Drug Agencies


12 July 2024 The forthcoming NSW Drug Summit is an opportunity to shelve outdated drug policies that have failed to deliver better health andwellbeing outcomes for individuals and their families. That’s the verdict from the peak organisation for the non-government drug and alcohol sector in NSW, the Network of Alcohol and other Drugs Agencies (NADA). NADA today welcomed the Government’s confirmation the NSW Drug Summit will be held over two days in regional NSW in October, and in Sydney on 4th and 5th December, as well as consultations about the Terms of Reference and other matters ahead of this. NADA…

  • Contains:
  • Medical Health Aged Care
  • 12/07/2024
  • 09:00
National Hypertension Taskforce - Australian Cardiovascular Alliance and Hypertension Australia

Australian Hypertension Taskforce unveils Roadmap to transform high blood pressure control and reduce preventable deaths

Raised blood pressure (BP), also known as hypertension, is a ‘silent killer’ and the leading cause of death in Australia, where it contributes to more than 25,000 deaths each year. It is also the leading risk factor for death from stroke, heart disease, kidney disease, and dementia, yet 68% of Australians with hypertension are uncontrolled. In response to this pressing issue, a Call to Action was published in 2022, leading to the establishment of the National Hypertension Taskforce, launched by Mark Butler MP, Minister for Health and Aged Care. The National Hypertension Taskforce, led by the Australian Cardiovascular Alliance and…

  • Medical Health Aged Care
  • 12/07/2024
  • 00:11
AI Medi Scan

AI Medi Scan Introduces New At-Home Skin Cancer Detection Technology

AI Medi Scan is developing a device that uses artificial intelligence (AI) and fluorescence imaging to allow Australians to conduct skin cancer checks at home, aiming to alleviate the impact of dermatologist shortages.SYDNEY, July 12, 2024 (GLOBE NEWSWIRE) -- AI Medi Scan, an Australian company, is pioneering a shift in skin cancer detection with its ongoing development of advanced diagnostic technologies. Aimed at empowering individuals and integrating with broader healthcare services, AI Medi Scan's long-term goal is to revolutionise how Australians address skin health, particularly in detecting melanoma, a prevalent cancer in the region.The company's current R&D efforts are focused…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.